Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate Long-Term Safety, Tolerability, and Satisfaction With Prucalopride in Chronic Constipation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Male and non-pregnant, non breast-feeding female outpatients at least 18 years of age.~2. Patient completed the entire treatment period of one of the following studies: PRU-USA-3, PRU-USA-11, PRU-USA-13, PRU-USA-21, PRU-USA-25, PRU-USA-27 or PRU-USA-28, or Patient participated in the re-treatment study PRU-USA-28 and did not qualify for Treatment period II after both washout periods.~Exclusion Criteria:~1. Patient with impaired renal function~2. Patient with clinically significant abnormalities of haematology, urinalysis, or blood chemistry.~3. Female of childbearing potential without adequate contraceptive protection during the study.~4. Patient who used an investigation drug other than prucalopride in the 30 days preceding the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).